echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The antiviral effect is not obvious. It is no longer recommended to use lopinavir tablets

    The antiviral effect is not obvious. It is no longer recommended to use lopinavir tablets

    • Last Update: 2020-02-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In February 17th, novel coronavirus pneumonia, a member of the medical treatment expert group of the national new type of coronavirus and Hu Bijie, director of infectious diseases department of Zhongshan Hospital Affiliated to Fudan University, told the Global Times: "there are no specific drugs for new infectious diseases The treatment plan for patients can be summarized by" groping and summarizing " According to Hu Bijie, the early used anti AIDS drug lopinavir and tonavir tablets may have side effects such as diarrhea in some patients The phased summary shows that the clinical effect of its anti-virus is not obvious, and it is no longer recommended The broad-spectrum antiviral drug abidol has some uses; gamma globulin has no obvious effect, and is not recommended The novel coronavirus pneumonia diagnosis and treatment plan has been used as an antiviral therapy in Lopinavir and Ritonavir Tablets In the fifth version of the trial, there were some reminders of the adverse reactions of Lopinavir and Ritonavir Tablets It is reported that glucocorticoids were used in some patients in the early stage Although they were used in small doses and short periods, they are not used as much as possible now Clinically, it was found that some patients without hormone had shorter detoxification period and longer detoxification time In addition, Hu Bijie said that many doctors and nurses who went to the front line of Wuhan injected thymosin to enhance immunity and prevent infection Some elderly people have novel coronavirus pneumonia, and their condition is easy to progress So, subcutaneous injection of thymosin is also considered It has certain effect on improving immune function, preventing severe disease and shortening the time of detoxification China's novel coronavirus novel coronavirus (COVID-19) is a new type of coronavirus (COVID-19), and it is related to the content of PD-1 and thymosin in 2019 patients with severe coronavirus infection.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.